CESCAIL
Multicentre NHS study sponsored by University Hospitals Coventry and Warwickshire with NIHR funding. It compares AiSPEED™-supported review of colon capsule studies with conventional reading.
A decade of running capsule services for national health systems, research programs and hospitals. Every study below links to its source.

Company-reported totals across CorporateHealth International (2015–2025) and GI Digital (since 2020). Most procedures were in Scotland, England, Denmark and the U.S., with further work in Germany, Poland, Portugal, Sweden and Canada.
Multicentre NHS study sponsored by University Hospitals Coventry and Warwickshire with NIHR funding. It compares AiSPEED™-supported review of colon capsule studies with conventional reading.
Home-delivered colon capsule endoscopy in national screening, with CorporateHealth International delivering and reading capsule studies in several trials.
A national colon capsule service built by NHS boards with the Medtronic and CorporateHealth International partnership.
A SmartBox-supported, remotely supervised home colon capsule service. A small feasibility study of delivery and patient acceptance.
Keck Hospital and the Keck School of Medicine of USC worked with GI Digital on a Tele-GI program using the SmartBox and PEARL™. Shown as project history.
The island's first capsule endoscopy service, launched in 2024 with GI Digital as general contractor. A second phase added a magnetically controlled gastric capsule.
Previously CE-marked and UKCA-registered as Class I software as a medical device under CorporateHealth International. Not FDA-cleared.
GI Digital uses the quality management system that was certified to ISO 13485 when it was operated by CorporateHealth International.
Grew from an early teleradiology system. Supports remote capsule-video analysis and reporting at Guam Regional Medical City (GRMC) and other hospitals and practices.
Logos and program names show that a defined relationship existed. Scope varied by organization and program, and a listing does not imply endorsement or current status.
We'll send our latest capsule evidence summary and the AiSPEED validation brief.